HTA Programme Funding Committee (commissioning) members
Lists of HTA Programme Funding Committee (commissioning) members).
- Published: 08 June 2022
Lists of HTA Programme Funding Committee (commissioning) members).
This document provides an example of a standard NIHR research contract between the Secretary of State for Health and Social Care and an NHS Trust.
This document provides an example of a standard research contract between Secretary of State for Health and Social Care and a higher education institution (HEI).
List of members of the HTA Prioritisation Committee A membership
List of members of the HTA Prioritisation Committee A membership
Guidance for researchers interested in carrying out a study within a trial (SWAT).
HTA Funding Committee Public Minutes 15 March 2022
HTA Funding Committee Public Minutes 8 - 9 March 2022
Information for applicants applying for Health communication and public health messaging
Innovative ventilation technologies for treatment of patients in ICU commissioning brief.
Guidance for applicants for HTA Funding Committee Deputy Chair vacancy
Commissioning brief
Minutes of meeting
Commissioning brief for 22/37 Non-pharmacological interventions for fatigue management in adults with long-term health conditions.
Commissioning brief for HTA topic 22/36 Microsuction compared with irrigation to remove earwax.
Commissioning brief for the HTA programme commissioned topic 22/32 Biologic disease-modifying anti-rheumatic drugs in pregnancy.
Commissioning brief for HTA topic 22/35 Thromboprophylaxis in lower limb immobilisation.
Commissioning brief for HTA topic 22/33 Botulinum toxin in the management of chronic masticatory myofascial pain.
Commissioning brief for HTA topic 22/34 Surgical and non-surgical management of basal thumb osteoarthritis.
Commissioning brief for HTA topic 22/30 Post-operative pain in patients undergoing spinal surgery.
Commissioning brief for HTA topic 22/29 Pseudomonas aeruginosa eradication treatment in bronchiectasis.
Commissioning brief for HTA topic 22/27 Antipsychotics for the treatment of borderline personality disorder.
Commissioning brief for HTA topic 22/28 Management of antipsychotic-induced sexual dysfunction.
Commissioning brief for HTA topic 22/31 Glucagon-like peptide-1 receptor agonist therapy for people with severe mental illness living with overweight or obesity.
HTA Stage 2 Guidance Notes for the 22/40 NIHR HTA Application development award – Towards evaluation of digital and technology-enabled healthcare.